By Helgi Library - April 2, 2020
Solvent CR's total assets reached CZK 5,630 mil at the end of 2016, up 10.5% compared to the previous year. Curren...
By Helgi Library - April 2, 2020
Solvent CR's total assets reached CZK 5,630 mil at the end of 2016, up 10.5% compared to the previous year. Curren...
| Profit Statement | 2014 | 2015 | 2016 | |
| Sales | CZK mil | 6,928 | 7,702 | 8,707 |
| Gross Profit | CZK mil | 921 | 1,086 | 1,224 |
| EBITDA | CZK mil | 524 | 679 | 679 |
| EBIT | CZK mil | 400 | 500 | 444 |
| Financing Cost | CZK mil | 36.9 | 56.4 | 53.6 |
| Pre-Tax Profit | CZK mil | 304 | 379 | 335 |
| Net Profit | CZK mil | 162 | 262 | 249 |
| Balance Sheet | 2014 | 2015 | 2016 | |
| Total Assets | CZK mil | 4,097 | 5,096 | 5,630 |
| Non-Current Assets | CZK mil | 1,244 | 1,490 | 1,776 |
| Current Assets | CZK mil | 2,741 | 3,409 | 3,644 |
| Working Capital | CZK mil | 1,664 | 2,769 | 3,079 |
| Shareholders' Equity | CZK mil | 2,341 | 2,459 | 2,742 |
| Liabilities | CZK mil | 1,756 | 2,637 | 2,888 |
| Total Debt | CZK mil | 1,053 | 888 | 1,305 |
| Net Debt | CZK mil | 966 | 729 | 1,192 |
| Ratios | 2014 | 2015 | 2016 | |
| ROE | % | 7.30 | 10.9 | 9.58 |
| ROCE | % | 5.78 | 7.32 | 5.47 |
| Gross Margin | % | 13.3 | 14.1 | 14.1 |
| EBITDA Margin | % | 7.57 | 8.82 | 7.80 |
| EBIT Margin | % | 5.78 | 6.49 | 5.09 |
| Net Margin | % | 2.33 | 3.41 | 2.86 |
| Net Debt/EBITDA | 1.84 | 1.07 | 1.76 | |
| Net Debt/Equity | % | 41.3 | 29.6 | 43.5 |
| Cost of Financing | % | 3.41 | 5.81 | 4.88 |
| Cash Flow | 2014 | 2015 | 2016 | |
| Cash Conversion Cycle | days | 98.0 | 144 | 143 |
| Cash Earnings | CZK mil | 286 | 442 | 484 |
Get all company financials in excel:
| summary | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
| income statement | |||||||||
| Sales | CZK mil | 4,711 | 4,692 | 5,590 | 6,421 | 6,928 | |||
| Gross Profit | CZK mil | 447 | 422 | 380 | 575 | 921 | |||
| EBIT | CZK mil | 315 | 317 | 270 | 432 | 400 | |||
| Net Profit | CZK mil | 202 | 192 | 197 | 160 | 162 | |||
| ROE | % | 18.2 | 14.2 | 12.5 | 8.48 | 7.30 | |||
| EBIT Margin | % | 6.69 | 6.75 | 4.83 | 6.72 | 5.78 | |||
| Net Margin | % | 4.29 | 4.10 | 3.52 | 2.49 | 2.33 | |||
| Employees | 1,217 | 1,259 | 1,946 | 2,030 | 2,229 | ||||
| balance sheet | |||||||||
| Total Assets | CZK mil | 1,800 | 1,944 | 3,196 | 3,712 | 4,097 | |||
| Non-Current Assets | CZK mil | 497 | 508 | 860 | 1,110 | 1,244 | |||
| Current Assets | CZK mil | 1,289 | 1,412 | 2,164 | 2,475 | 2,741 | |||
| Shareholders' Equity | CZK mil | 1,231 | 1,482 | 1,681 | 2,084 | 2,341 | |||
| Liabilities | CZK mil | 569 | 462 | 1,515 | 1,628 | 1,756 | |||
| Non-Current Liabilities | CZK mil | 17.8 | 18.0 | 337 | 355 | 408 | |||
| Current Liabilities | CZK mil | 325 | 374 | 649 | 590 | 696 | |||
| Net Debt/EBITDA | 0.553 | 0.036 | 2.30 | 1.90 | 1.84 | ||||
| Net Debt/Equity | % | 16.2 | 0.854 | 44.1 | 47.5 | 41.3 | |||
| Cost of Financing | % | ... | 3.35 | 3.12 | 0.966 | 3.30 | 3.41 |
| income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
| income statement | |||||||||
| Sales | CZK mil | 4,711 | 4,692 | 5,590 | 6,421 | 6,928 | |||
| Cost of Goods & Services | CZK mil | 4,264 | 4,270 | 5,210 | 5,846 | 6,008 | |||
| Gross Profit | CZK mil | 447 | 422 | 380 | 575 | 921 | |||
| Staff Cost | CZK mil | 389 | 391 | 520 | 553 | 664 | |||
| Other Cost | CZK mil | -303 | -323 | -462 | -499 | -268 | |||
| EBITDA | CZK mil | 361 | 354 | 323 | 521 | 524 | |||
| Depreciation | CZK mil | 46.5 | 37.4 | 52.6 | 89.1 | 124 | |||
| EBIT | CZK mil | 315 | 317 | 270 | 432 | 400 | |||
| Financing Cost | CZK mil | 13.2 | 5.89 | 4.92 | 33.2 | 36.9 | |||
| Extraordinary Cost | CZK mil | 26.3 | 50.5 | -19.9 | 139 | 59.6 | |||
| Pre-Tax Profit | CZK mil | 275 | 260 | 285 | 260 | 304 | |||
| Tax | CZK mil | 60.7 | 54.2 | 63.0 | 69.4 | 99.7 | |||
| Minorities | CZK mil | 12.6 | 13.9 | 24.9 | 30.9 | 42.5 | |||
| Net Profit | CZK mil | 202 | 192 | 197 | 160 | 162 | |||
| growth rates | |||||||||
| Total Revenue Growth | % | ... | 15.6 | -0.398 | 19.1 | 14.9 | 7.90 | ||
| Operating Cost Growth | % | ... | -27.3 | -20.2 | -15.3 | -5.17 | 624 | ||
| EBITDA Growth | % | ... | 84.0 | -2.01 | -8.91 | 61.4 | 0.683 | ||
| EBIT Growth | % | ... | 97.2 | 0.580 | -14.8 | 59.9 | -7.26 | ||
| Pre-Tax Profit Growth | % | ... | 111 | -5.48 | 9.46 | -8.81 | 16.9 | ||
| Net Profit Growth | % | ... | 106 | -4.88 | 2.45 | -19.0 | 1.23 | ||
| ratios | |||||||||
| ROE | % | 18.2 | 14.2 | 12.5 | 8.48 | 7.30 | |||
| ROCE | % | ... | 14.5 | 13.2 | 10.3 | 6.34 | 5.78 | ||
| Gross Margin | % | 9.49 | 9.00 | 6.80 | 8.96 | 13.3 | |||
| EBITDA Margin | % | 7.67 | 7.55 | 5.77 | 8.11 | 7.57 | |||
| EBIT Margin | % | 6.69 | 6.75 | 4.83 | 6.72 | 5.78 | |||
| Net Margin | % | 4.29 | 4.10 | 3.52 | 2.49 | 2.33 | |||
| Cost of Financing | % | ... | 3.35 | 3.12 | 0.966 | 3.30 | 3.41 | ||
| Net Debt/EBITDA | 0.553 | 0.036 | 2.30 | 1.90 | 1.84 |
| balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
| balance sheet | |||||||||
| Non-Current Assets | CZK mil | 497 | 508 | 860 | 1,110 | 1,244 | |||
| Property, Plant & Equipment | CZK mil | 500 | 510 | 802 | 1,045 | 1,188 | |||
| Intangible Assets | CZK mil | -4.25 | 0.792 | 6.06 | 12.2 | 13.9 | |||
| Current Assets | CZK mil | 1,289 | 1,412 | 2,164 | 2,475 | 2,741 | |||
| Inventories | CZK mil | 807 | 886 | 1,442 | 1,655 | 1,766 | |||
| Receivables | CZK mil | 273 | 243 | 310 | 372 | 389 | |||
| Cash & Cash Equivalents | CZK mil | 64.4 | 101 | 162 | 122 | 87.4 | |||
| Total Assets | CZK mil | 1,800 | 1,944 | 3,196 | 3,712 | 4,097 | |||
| Shareholders' Equity | CZK mil | 1,231 | 1,482 | 1,681 | 2,084 | 2,341 | |||
| Of Which Minority Interest | CZK mil | 31.3 | 36.1 | 70.1 | 107 | 153 | |||
| Liabilities | CZK mil | 569 | 462 | 1,515 | 1,628 | 1,756 | |||
| Non-Current Liabilities | CZK mil | 17.8 | 18.0 | 337 | 355 | 408 | |||
| Long-Term Debt | CZK mil | 17.8 | 18.0 | 337 | 355 | 408 | |||
| Deferred Tax Liabilities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||
| Current Liabilities | CZK mil | 325 | 374 | 649 | 590 | 696 | |||
| Short-Term Debt | CZK mil | 246 | 95.6 | 567 | 756 | 645 | |||
| Trade Payables | CZK mil | 145 | 146 | 265 | 450 | 492 | |||
| Provisions | CZK mil | 4.18 | 3.97 | 5.28 | 4.50 | 141 | |||
| Equity And Liabilities | CZK mil | 1,800 | 1,944 | 3,196 | 3,712 | 4,097 | |||
| growth rates | |||||||||
| Total Asset Growth | % | ... | -0.076 | 8.01 | 64.4 | 16.1 | 10.4 | ||
| Shareholders' Equity Growth | % | ... | 24.4 | 20.5 | 13.4 | 24.0 | 12.3 | ||
| Net Debt Growth | % | ... | -51.1 | -93.7 | 5,757 | 33.4 | -2.36 | ||
| Total Debt Growth | % | ... | -49.7 | -57.0 | 696 | 23.0 | -5.24 | ||
| ratios | |||||||||
| Total Debt | CZK mil | 264 | 114 | 904 | 1,111 | 1,053 | |||
| Net Debt | CZK mil | 200 | 12.7 | 742 | 989 | 966 | |||
| Working Capital | CZK mil | 936 | 983 | 1,488 | 1,577 | 1,664 | |||
| Capital Employed | CZK mil | 1,432 | 1,491 | 2,347 | 2,686 | 2,908 | |||
| Net Debt/Equity | % | 16.2 | 0.854 | 44.1 | 47.5 | 41.3 | |||
| Cost of Financing | % | ... | 3.35 | 3.12 | 0.966 | 3.30 | 3.41 |
| cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
| cash flow | |||||||||
| Net Profit | CZK mil | 202 | 192 | 197 | 160 | 162 | |||
| Depreciation | CZK mil | 46.5 | 37.4 | 52.6 | 89.1 | 124 | |||
| ratios | |||||||||
| Days Sales Outstanding | days | 21.1 | 18.9 | 20.2 | 21.1 | 20.5 | |||
| Days Sales Of Inventory | days | 69.1 | 75.7 | 101 | 103 | 107 | |||
| Days Payable Outstanding | days | 12.4 | 12.5 | 18.5 | 28.1 | 29.9 | |||
| Cash Conversion Cycle | days | 77.9 | 82.2 | 103 | 96.4 | 98.0 | |||
| Cash Earnings | CZK mil | 249 | 230 | 250 | 249 | 286 |
| other data | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
| other data | |||||||||
| ROA | % | 11.2 | 10.3 | 7.67 | 4.62 | 4.14 | |||
| Gross Margin | % | 9.49 | 9.00 | 6.80 | 8.96 | 13.3 | |||
| Employees | 1,217 | 1,259 | 1,946 | 2,030 | 2,229 | ||||
| Cost Per Employee | USD per month | 1,392 | 1,464 | 1,139 | 1,161 | 1,162 | |||
| Cost Per Employee (Local Currency) | CZK per month | 26,606 | 25,889 | 22,271 | 22,712 | 24,829 | |||
| Staff Cost (As % Of Total Cost) | % | 8.84 | 8.94 | 9.78 | 9.24 | 10.2 | |||
| Effective Tax Rate | % | 22.0 | 20.8 | 22.1 | 26.7 | 32.8 |
Get all company financials in excel:
Solvent CR s.r.o. is a Czech Republic-based drug store chain. It operates 700 drug retail outlets under the brand name TETA. The company was founded in 1992 and is based in Sestajovice, Czech Republic.
Solvent CR has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 13.9% a year during that time to total of CZK 679 mil in 2016, or 7.80% of sales. That’s compared to 7.61% average margin seen in last five years.
The company netted CZK 249 mil in 2016 implying ROE of 9.58% and ROCE of 5.47%. Again, the average figures were 9.75% and 7.04%, respectively when looking at the previous 5 years.
Solvent CR’s net debt amounted to CZK 1,192 mil at the end of 2016, or 43.5% of equity. When compared to EBITDA, net debt was 1.76x, down when compared to average of 1.77x seen in the last 5 years.
Helgi Library 
